Long-term retention rate of pramipexole in the treatment of Parkinson’s disease

被引:0
|
作者
Tapani Keränen
Mervi Tuhkasaari
Hanna Kuusisto
机构
[1] Tampere University Hospital,Division of Neurology and Rehabilitation
[2] University of Kuopio,Department of Pharmacology and Toxicology
关键词
Outcome; Parkinson’s disease; Pramipexole; Retention rate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:955 / 956
页数:1
相关论文
共 50 条
  • [21] RLS augmentation and pramipexole long-term treatment
    Ferini-Strambi, L
    Oldani, A
    Castronovo, V
    Zucconi, M
    NEUROLOGY, 2001, 56 (08) : A20 - A21
  • [22] Long-term efficacy of posteroventral pallidotomy in the treatment of Parkinson's disease
    Lai, EC
    Jankovic, J
    Krauss, JK
    Ondo, WG
    Grossman, RG
    NEUROLOGY, 2000, 55 (08) : 1218 - 1222
  • [23] Long-term treatment with dopamine agonists in idiopathic in Parkinson's disease
    H. Reichmann
    Journal of Neurology, 2000, 247 (Suppl 4) : IV17 - IV19
  • [24] Long-term safety and efficacy of selegiline in the treatment of Parkinson's disease
    Maki-Ikola, O
    Heinonen, E
    Lammintausta, R
    NEUROCHEMISTRY: CELLULAR, MOLECULAR, AND CLINICAL ASPECTS, 1997, : 331 - 337
  • [25] Long-term treatment with dopamine agonists in idiopathic Parkinson's disease
    Reichmann, H
    JOURNAL OF NEUROLOGY, 2000, 247 : 17 - 19
  • [26] Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
    Poewe, W.
    Barone, P.
    Hauser, R.
    Mizuno, Y.
    Rascol, O.
    Busse, M.
    Debieuvre, C.
    Fraessdorf, M.
    Schapira, A.
    MOVEMENT DISORDERS, 2011, 26 : S137 - S138
  • [27] Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
    Hauser, R. A.
    Schapira, A. H. V.
    Barone, P.
    Mizuno, Y.
    Rascol, O.
    Busse, M.
    Debieuvre, C.
    Fraessdorf, M.
    Poewe, W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (05) : 736 - 743
  • [28] Long-term efficacy and safety of pramipexole in advanced Parkinson's disease:: Results from a European multicenter trial
    Möller, JC
    Oertel, WH
    Köster, J
    Pezzoli, G
    Provinciali, L
    MOVEMENT DISORDERS, 2005, 20 (05) : 602 - 610
  • [29] Long-term course of Parkinson's disease
    Ebersbach, G.
    NERVENHEILKUNDE, 2010, 29 (06) : 345 - 350
  • [30] Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response
    Vitale, Antonio
    Cavalli, Giulio
    Colafrancesco, Serena
    Priori, Roberta
    Valesini, Guido
    Argolini, Lorenza Maria
    Baldissera, Elena
    Bartoloni, Elena
    Cammelli, Daniele
    Canestrari, Giovanni
    Sota, Jurgen
    Cavallaro, Elena
    Massaro, Maria Grazia
    Ruscitti, Piero
    Cipriani, Paola
    De Marchi, Ginevra
    De Vita, Salvatore
    Emmi, Giacomo
    Ferraccioli, Gianfranco
    Frassi, Micol
    Gerli, Roberto
    Gremese, Elisa
    Iannone, Florenzo
    Lapadula, Giovanni
    Lopalco, Giuseppe
    Manna, Raffaele
    Mathieu, Alessandro
    Montecucco, Carlomaurizio
    Mosca, Marta
    Piazza, Ilaria
    Piga, Matteo
    Pontikaki, Irene
    Romano, Micol
    Rossi, Silvia
    Rossini, Maurizio
    Silvestri, Elena
    Stagnaro, Chiara
    Talarico, Rosaria
    Tincani, Angela
    Viapiana, Ombretta
    Vitiello, Gianfranco
    Galozzi, Paola
    Sfriso, Paolo
    Gaggiano, Carla
    Rigante, Donato
    Dagna, Lorenzo
    Giacomelli, Roberto
    Cantarini, Luca
    FRONTIERS IN PHARMACOLOGY, 2019, 10